PMID: 24958810

Sharma H, Mavuduru RS, Singh SK, Prasad R
Heterogeneous spectrum of mutations in CFTR gene from Indian patients with congenital absence of the vas deferens and their association with cystic fibrosis genetic modifiers.
Mol Hum Reprod. 2014 Sep;20(9):827-35. doi: 10.1093/molehr/gau047. Epub 2014 Jun 23., [PubMed]
Sentences
No. Mutations Sentence Comment
4 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 24958810:4:31
status: NEW
view ABCC7 p.Arg117His details
p.Phe508del (n &#bc; 16) and p.Arg117His (n &#bc; 4) were among the most common severe forms of CFTR mutations identified.TheIVS8-T5 allele,which isconsideredas amild formofCFTR mutation,wasfound withan allelicfrequencyof28.3%. Login to comment
21 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 24958810:21:19
status: NEW
view ABCC7 p.Arg117His details
The p.Phe508del, p.Arg117His and T5 allele were identified as most common CFTR mutations in Caucasians associated with CAVD phenotype (Chillon et al., 1995; De Braekeller and Ferec, 1996). Login to comment
56 ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 24958810:56:137
status: NEW
view ABCC7 p.Gly551Asp details
ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 24958810:56:24
status: NEW
view ABCC7 p.Arg117His details
ABCC7 p.Asn1303Lys
X
ABCC7 p.Asn1303Lys 24958810:56:37
status: NEW
view ABCC7 p.Asn1303Lys details
CFTR mutations, viz., p.Arg117His, p.Asn1303Lys and p.Arg553X were analyzed by single ARMS PCR, whereas mutations 621+1G.T, p.Gly542X, p.Gly551Asp and p.Trp1282X were screened by multiplex ARMS PCR. Login to comment
73 ABCC7 p.Gly126Cys
X
ABCC7 p.Gly126Cys 24958810:73:68
status: NEW
view ABCC7 p.Gly126Cys details
Among eight patients identified with novel variant, only one with p.Gly126Cys mutation was observed with a slight elevated sweat chloride level (64mEq/l); however, in the remaining seven patients, sweat chloride level was in the intermediate range. Login to comment
76 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 24958810:76:31
status: NEW
view ABCC7 p.Arg117His details
p.Phe508del (n &#bc; 16) and p.Arg117His (n &#bc; 4) are the most common severe form of CFTR mutations identified in the Indian CAVD males. Login to comment
82 ABCC7 p.Ser549Asn
X
ABCC7 p.Ser549Asn 24958810:82:100
status: NEW
view ABCC7 p.Ser549Asn details
ABCC7 p.Arg170Cys
X
ABCC7 p.Arg170Cys 24958810:82:178
status: NEW
view ABCC7 p.Arg170Cys details
ABCC7 p.His139Gln
X
ABCC7 p.His139Gln 24958810:82:152
status: NEW
view ABCC7 p.His139Gln details
ABCC7 p.Gly126Cys
X
ABCC7 p.Gly126Cys 24958810:82:126
status: NEW
view ABCC7 p.Gly126Cys details
ABCC7 p.Gly480Ser
X
ABCC7 p.Gly480Ser 24958810:82:87
status: NEW
view ABCC7 p.Gly480Ser details
ABCC7 p.Arg933Thr
X
ABCC7 p.Arg933Thr 24958810:82:217
status: NEW
view ABCC7 p.Arg933Thr details
ABCC7 p.Ala141Gly
X
ABCC7 p.Ala141Gly 24958810:82:139
status: NEW
view ABCC7 p.Ala141Gly details
ABCC7 p.Met281Arg
X
ABCC7 p.Met281Arg 24958810:82:204
status: NEW
view ABCC7 p.Met281Arg details
ABCC7 p.Arg518Lys
X
ABCC7 p.Arg518Lys 24958810:82:113
status: NEW
view ABCC7 p.Arg518Lys details
ABCC7 p.Ser118Pro
X
ABCC7 p.Ser118Pro 24958810:82:165
status: NEW
view ABCC7 p.Ser118Pro details
ABCC7 p.Glu585Gln
X
ABCC7 p.Glu585Gln 24958810:82:191
status: NEW
view ABCC7 p.Glu585Gln details
SSCP analysis and subsequent DNA sequencing further revealed eleven mutations, viz., p.Gly480Ser, p.Ser549Asn, p.Arg518Lys, p.Gly126Cys, p.Ala141Gly, p.His139Gln, p.Ser118Pro, p.Arg170Cys, p.Glu585Gln, p.Met281Arg, p.Arg933Thr and two intronic variants c.1679+24G.T, c.1766+48G.C. Login to comment
83 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 24958810:83:187
status: NEW
view ABCC7 p.Arg117His details
Among them, eight mutations were novel and have been reported only in the Indian CAVD male population(TableII).Among50healthycontrolsscreenedforthecommonmuta- tions, viz., p.Phe508del, p.Arg117His and T5 allele, only seven of them were detected as a carrier of T5 allele (Table III and Supplementary data, Table SII). Login to comment
86 ABCC7 p.Gly126Cys
X
ABCC7 p.Gly126Cys 24958810:86:16
status: NEW
view ABCC7 p.Gly126Cys details
ABCC7 p.Arg933Thr
X
ABCC7 p.Arg933Thr 24958810:86:52
status: NEW
view ABCC7 p.Arg933Thr details
ABCC7 p.Met281Arg
X
ABCC7 p.Met281Arg 24958810:86:40
status: NEW
view ABCC7 p.Met281Arg details
ABCC7 p.Ser118Pro
X
ABCC7 p.Ser118Pro 24958810:86:28
status: NEW
view ABCC7 p.Ser118Pro details
edu/pph2/)for p.Gly126Cys,p.Ser118Pro,p.Met281Arg,p.Arg933Thr were more than 0.5 (threshold for pathological mutation) and therefore categorized as deleterious mutations and may possibly affect CFTR structure and function (Table IV). Login to comment
90 ABCC7 p.Arg933Thr
X
ABCC7 p.Arg933Thr 24958810:90:31
status: NEW
view ABCC7 p.Arg933Thr details
ABCC7 p.Met281Arg
X
ABCC7 p.Met281Arg 24958810:90:15
status: NEW
view ABCC7 p.Met281Arg details
ABCC7 p.Ser118Pro
X
ABCC7 p.Ser118Pro 24958810:90:2
status: NEW
view ABCC7 p.Ser118Pro details
p.Ser118Pro, p.Met281Arg and p.Arg933Thr as pathological damaging CFTR mutations, whereas five other novel mutations were predicted as being neutral by this program (Supplementary data, Table SIII). Login to comment
94 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 24958810:94:140
status: NEW
view ABCC7 p.Arg117His details
ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 24958810:94:160
status: NEW
view ABCC7 p.Arg117His details
ABCC7 p.His139Gln
X
ABCC7 p.His139Gln 24958810:94:199
status: NEW
view ABCC7 p.His139Gln details
ABCC7 p.Arg933Thr
X
ABCC7 p.Arg933Thr 24958810:94:180
status: NEW
view ABCC7 p.Arg933Thr details
ABCC7 p.Ser118Pro
X
ABCC7 p.Ser118Pro 24958810:94:218
status: NEW
view ABCC7 p.Ser118Pro details
Genotype Number of CAVD subjects (n 5 60) Number of healthy controls (n 5 50) p.Phe508del/U 11 ND p.Phe508del/5T 5 ND 5T/5T 8 ND 5T/U 9 7 p.Arg117His/7T 2 ND p.Arg117His/5T 2 ND p.Arg933Thr/U 1 ND p.His139Gln/U 1 ND p.Ser118Pro/c. Login to comment
95 ABCC7 p.Ser549Asn
X
ABCC7 p.Ser549Asn 24958810:95:95
status: NEW
view ABCC7 p.Ser549Asn details
ABCC7 p.Arg170Cys
X
ABCC7 p.Arg170Cys 24958810:95:38
status: NEW
view ABCC7 p.Arg170Cys details
ABCC7 p.Gly126Cys
X
ABCC7 p.Gly126Cys 24958810:95:57
status: NEW
view ABCC7 p.Gly126Cys details
ABCC7 p.Gly480Ser
X
ABCC7 p.Gly480Ser 24958810:95:76
status: NEW
view ABCC7 p.Gly480Ser details
ABCC7 p.Ala141Gly
X
ABCC7 p.Ala141Gly 24958810:95:134
status: NEW
view ABCC7 p.Ala141Gly details
ABCC7 p.Arg518Lys
X
ABCC7 p.Arg518Lys 24958810:95:115
status: NEW
view ABCC7 p.Arg518Lys details
ABCC7 p.Glu585Gln
X
ABCC7 p.Glu585Gln 24958810:95:173
status: NEW
view ABCC7 p.Glu585Gln details
1679+24G.T 1 ND p.Meth281Arg/U 1 ND p.Arg170Cys/U 1 ND p.Gly126Cys/U 1 ND p.Gly480Ser/U 1 ND p.Ser549Asn/5T 1 ND p.Arg518Lys/U 1 ND p.Ala141Gly/U 1 ND c.1766+48G.C/U 1 ND p.Glu585Gln/5T 1 ND In 11 CAVD patients, no mutation could be detected in either CFTR allele U-unidentified; ND, not detected. Login to comment
100 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 24958810:100:376
status: NEW
view ABCC7 p.Arg117His details
ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 24958810:100:395
status: NEW
view ABCC7 p.Arg117His details
ABCC7 p.Ser549Asn
X
ABCC7 p.Ser549Asn 24958810:100:909
status: NEW
view ABCC7 p.Ser549Asn details
ABCC7 p.Ser549Asn
X
ABCC7 p.Ser549Asn 24958810:100:929
status: NEW
view ABCC7 p.Ser549Asn details
ABCC7 p.Arg170Cys
X
ABCC7 p.Arg170Cys 24958810:100:666
status: NEW
view ABCC7 p.Arg170Cys details
ABCC7 p.Gly480Ser
X
ABCC7 p.Gly480Ser 24958810:100:260
status: NEW
view ABCC7 p.Gly480Ser details
ABCC7 p.Gly480Ser
X
ABCC7 p.Gly480Ser 24958810:100:280
status: NEW
view ABCC7 p.Gly480Ser details
ABCC7 p.Arg933Thr
X
ABCC7 p.Arg933Thr 24958810:100:868
status: NEW
view ABCC7 p.Arg933Thr details
ABCC7 p.Ala141Gly
X
ABCC7 p.Ala141Gly 24958810:100:512
status: NEW
view ABCC7 p.Ala141Gly details
ABCC7 p.Met281Arg
X
ABCC7 p.Met281Arg 24958810:100:806
status: NEW
view ABCC7 p.Met281Arg details
ABCC7 p.Arg518Lys
X
ABCC7 p.Arg518Lys 24958810:100:338
status: NEW
view ABCC7 p.Arg518Lys details
ABCC7 p.Ser118Pro
X
ABCC7 p.Ser118Pro 24958810:100:630
status: NEW
view ABCC7 p.Ser118Pro details
ABCC7 p.Glu585Gln
X
ABCC7 p.Glu585Gln 24958810:100:744
status: NEW
view ABCC7 p.Glu585Gln details
Mutations Nucleotide change Consequences Exon/Intron Number of alleles T5 Reduction of oligo T tract to 5T, c.1210-12T[5] Aberrant splicing Intron 8 34 p.Phe508del c.1521_1523delCTT or c.1522_1524delTTT Deletion of phenylalanine at amino acid 508 Exon 11 16 p.Gly480Ser c.1438G.A Glycine to Serine at 480 Exon 11 1 p.Arg518Lysa c.1553G.A Arginine to Lysine at 518 Exon 11 1 p.Arg117His c.350G.A Arginine to Histidine at 117 Exon 4 4 p.Gly126Cysa c.376G.T Glycine to Cystine at 126 Exon 4 1 p.Ala141Glya c.422C.G Alanine to Glycine at 141 Exon 4 1 p.His139Glna c.417C.G Histadine to Glutamine at 139 Exon 4 1 p.Ser118Proa c.352T.C Serine to Proline at 118 Exon 4 1 p.Arg170Cys c.508C.T Arginine to Cystine at 170 Exon 5 1 p.Glu585Glna c.1753G.C Glutamate to Glutamine at 585 Exon 13 1 p.Met281Arga c.842T.G Methionine to Arginine at 281 Exon 7 1 p.Arg933Thra c.2798G.C Arginine to Threonine at 933 Exon 17 1 p.Ser549Asn c.1646G.A Serine to Asparagine at 549 Exon 12 1 CTFR, cystic fibrosis transmembrane conductance regulator. Login to comment
105 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 24958810:105:195
status: NEW
view ABCC7 p.Arg117His details
However, no significant association was established between CF genetic modifiers (TGF-b1 and EDNRA) and the most common mutations identified in the Indian CAVD males, namely viz., p.Phe508del, p.Arg117His and IVS8-T5. Login to comment
121 ABCC7 p.Ser549Asn
X
ABCC7 p.Ser549Asn 24958810:121:25
status: NEW
view ABCC7 p.Ser549Asn details
One patient with a T5/ p.Ser549Asn genotype presented with the symptoms of repeated respiratory infection since childhood. Login to comment
135 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 24958810:135:49
status: NEW
view ABCC7 p.Arg117His details
The second most common mutation identified was p.Arg117His observed with an allelic frequency of 3.3%, and this frequency is similar to that of France (Grangeia et al., 2004) and Greece (Estivill et al., 1997) but lower than that of Germany (11%; Dork et al., 1997). Login to comment
136 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 24958810:136:29
status: NEW
view ABCC7 p.Arg117His details
Two of the patients with a p.Arg117His heterozygous mutation were associated with a T7 allele, which is considered a mild CFTR mutation in Europe and may lead to the CAVD phenotype (Thauvin et al., 2009). Login to comment
141 ABCC7 p.Ser549Asn
X
ABCC7 p.Ser549Asn 24958810:141:223
status: NEW
view ABCC7 p.Ser549Asn details
ABCC7 p.Arg170Cys
X
ABCC7 p.Arg170Cys 24958810:141:239
status: NEW
view ABCC7 p.Arg170Cys details
ABCC7 p.Gly480Ser
X
ABCC7 p.Gly480Ser 24958810:141:210
status: NEW
view ABCC7 p.Gly480Ser details
Intriguingly, extensive screening of 27 exons of CFTR in Indian CAVD males leads to the identification of eight novel substitutions which are reported only in the Indian population and three mutations, viz., p.Gly480Ser, p.Ser549Asn and p.Arg170Cys, which havebeen reported previously (Curtis et al., 1993; Fere et al., 1994; Kawose et al., 2001). Login to comment
144 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 24958810:144:123
status: NEW
view ABCC7 p.Arg117His details
As the frequency of novel substitutions identified in the Indian CAVD male is very low, we can include only p.Phe508del, p.Arg117His and T5 in mutation screening panel. Login to comment
147 ABCC7 p.His139Gln
X
ABCC7 p.His139Gln 24958810:147:162
status: NEW
view ABCC7 p.His139Gln details
ABCC7 p.Gly126Cys
X
ABCC7 p.Gly126Cys 24958810:147:72
status: NEW
view ABCC7 p.Gly126Cys details
ABCC7 p.Arg933Thr
X
ABCC7 p.Arg933Thr 24958810:147:85
status: NEW
view ABCC7 p.Arg933Thr details
ABCC7 p.Ala141Gly
X
ABCC7 p.Ala141Gly 24958810:147:149
status: NEW
view ABCC7 p.Ala141Gly details
ABCC7 p.Met281Arg
X
ABCC7 p.Met281Arg 24958810:147:59
status: NEW
view ABCC7 p.Met281Arg details
ABCC7 p.Arg518Lys
X
ABCC7 p.Arg518Lys 24958810:147:136
status: NEW
view ABCC7 p.Arg518Lys details
ABCC7 p.Ser118Pro
X
ABCC7 p.Ser118Pro 24958810:147:46
status: NEW
view ABCC7 p.Ser118Pro details
ABCC7 p.Glu585Gln
X
ABCC7 p.Glu585Gln 24958810:147:175
status: NEW
view ABCC7 p.Glu585Gln details
Among the eight novel mutations identified, p.Ser118Pro, p.Met281Arg, p.Gly126Cys, p.Arg933Thr were predicted to be damaging, whereas p.Arg518Lys, p.Ala141Gly, p.His139Gln, p.Glu585Gln were possibly neutral mutations (http://genetics.bwh.harvard.edu/ pph2/). Login to comment